Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02322281
Title TIGER-3 Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Directed TKI and Platinum-doublet Chemotherapy
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Clovis Oncology, Inc.
Indications

lung non-small cell carcinoma

Therapies

Pemetrexed Disodium

Gemcitabine

Paclitaxel

Docetaxel

Rociletinib

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU


No variant requirements are available.